Professional Documents
Culture Documents
In Millions of INR, except per share items. Currency: Indian Rupee Conversion: Historical
Order: Latest on Right Units: S&P Capital IQ (Default)
Decimals: Capital IQ (Default) Dilution: Basic
Key Financials¹
LTM²
Press Release
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months†
Mar-31-2016A Mar-31-2017A Mar-31-2018A Mar-31-2019A Sep-30-2019A Mar-31-2020E
Currency INR INR INR INR INR INR
Diluted EPS Excl. Extra Items³ 16.99 15.88 8.44 16.97 20.28 25.85
Growth Over Prior Year (30.5%) (6.5%) (46.9%) 101.0% NA 52.30%
¹All results are taken from the most recently filed statement for each period. When there has been more than one, earlier filings can be viewed on the individual statement pages.
²Growth rates for the LTM period are calculated against the LTM period ending 12 months before.
³All forward period figures are consensus mean estimates provided by the brokers and may not be on a comparable basis as financials.
†Growth rates for forward periods are calculated against prior period estimates or actual pro forma results as disclosed on the Estimates Consensus page.
Growth Rates are calculated in originally reported currency only and will not reflect any currency conversion selected above.
**For companies that have multiple share classes that publicly trade,
we are incorporating the different prices to calculate our company level
market capitalization. Please click on the value to see the detailed
calculation. Prices shown on this page are the close price of the
company’s primary stock class. Shares shown on this page are total
company as-reported share values.
Total Liability includes Total Debt, Minority Interest and Pref. Equity.
Net Liability includes Total Liability, net of Cash and Short Term Investments.
TEV includes Market Cap and Net Liability.
Total Capital includes Common Equity and Total Liability.
122,871.11 138,411.64
10.96% 12.65%
- -
51.20% 51.74%
16,549.0 19,578.0
13.47% 14.14%
10,837.84 12,944.69
8.82% 9.35%
- -
- -
5,032.12 6,882.82
4.10% 4.97%
36.21 49.4
40.11% 36.41%
INR INR
1.0 1.0
S S
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) > Financials > Income Statement
In Millions of INR, except per share items. Template: Standard Restatement: Latest Filings
Period Type: Annual Order: Latest on Right
Currency: Indian Rupee Conversion: Historical
Units: S&P Capital IQ (Defaul Decimals: Capital IQ (Default)
Income Statement
LTM
Reclassified Restated Restated Reclassified Press Release
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019 Sep-30-2019
Currency INR INR INR INR INR INR
Selling General & Admin Exp. 3,347.5 4,227.6 4,555.7 5,063.9 5,475.9 5,475.9
Provision for Bad Debts 258.7 239.0 180.1 110.9 429.8 429.8
Stock-Based Compensation - - 4.4 - - -
R & D Exp. - - - - - -
Depreciation & Amort. 2,116.5 2,638.3 3,140.4 3,590.3 3,955.3 5,018.3
Other Operating Expense/(Income) 6,381.2 9,955.3 11,638.8 13,973.8 15,974.3 16,088.9
Other Operating Exp., Total 12,103.9 17,060.3 19,519.3 22,738.8 25,835.3 27,012.9
Impairment of Goodwill - - - - - -
Gain (Loss) On Sale Of Invest. 104.0 184.3 2.8 - 0.0 0.0
Gain (Loss) On Sale Of Assets (27.7) (36.8) (46.9) (80.1) (14.7) (14.7)
Other Unusual Items 135.0 159.4 - - - -
EBT Incl. Unusual Items 4,647.7 3,321.2 2,220.8 1,714.6 3,735.4 4,429.7
Income Tax Expense 1,300.0 969.0 909.6 1,119.1 1,733.7 1,880.2
Earnings from Cont. Ops. 3,347.6 2,352.3 1,311.2 595.6 2,001.7 2,549.5
NI to Common Incl Extra Items 3,399.0 2,363.8 2,209.9 1,174.2 2,360.5 2,821.2
NI to Common Excl. Extra Items 3,399.0 2,363.8 2,209.9 1,174.2 2,360.5 2,821.2
Shares per Depository Receipt 1.0 1.0 1.0 1.0 1.0 1.0
Supplemental Items
EBITDA 7,384.9 6,875.4 7,257.6 7,855.0 10,508.1 12,268.5
EBITA 5,344.1 4,348.5 4,246.4 4,447.2 6,754.7 8,413.8
EBIT 5,268.4 4,303.3 4,197.5 4,422.0 6,741.8 8,400.9
EBITDAR 9,177.4 9,534.1 10,493.0 11,176.1 14,145.2 NA
As Reported Total Revenue* 52,152.1 62,596.8 72,782.0 82,756.2 96,488.8 104,447.8
Effective Tax Rate % 28.0% 29.2% 41.0% 65.3% 46.4% 42.4%
Current Domestic Taxes 559.9 NA NA NA NA NA
Total Current Taxes 559.9 1,020.4 835.8 883.7 1,258.8 1,874.0
Deferred Domestic Taxes 740.1 NA NA NA NA NA
Total Deferred Taxes 740.1 (51.5) 73.8 235.4 474.9 6.2
Balance Sheet
Balance Sheet as of: Restated Restated Restated Press Release
Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019 Sep-30-2019
Currency INR INR INR INR INR INR
ASSETS
Cash And Equivalents 3,773.3 3,419.8 2,827.8 3,063.3 2,862.1 4,918.1
Short Term Investments 1,455.7 78.4 - - - 2,564.7
Trading Asset Securities - 739.0 1,058.5 578.7 688.3 -
Total Cash & ST Investments 5,229.0 4,237.2 3,886.3 3,642.1 3,550.4 7,482.8
Gross Property, Plant & Equipment 45,761.2 47,835.7 54,271.7 62,850.5 69,566.8 -
Accumulated Depreciation (10,106.7) (5,771.2) (8,710.0) (11,942.9) (15,411.2) -
Net Property, Plant & Equipment 35,654.6 42,064.5 45,561.7 50,907.6 54,155.6 70,391.6
LIABILITIES
Accounts Payable 4,191.4 5,501.9 5,011.9 6,060.2 7,131.2 7,896.7
Accrued Exp. 1,202.1 2,419.9 1,386.8 1,285.3 1,946.4 932.7
Short-term Borrowings 857.4 1,829.3 706.9 3,791.7 4,981.6 6,474.0
Curr. Port. of LT Debt 1,784.6 2,008.0 998.2 1,220.8 2,209.8 -
Curr. Port. of Cap. Leases - - 14.1 15.9 17.9 -
Curr. Income Taxes Payable 163.8 - - 12.7 10.6 10.4
Unearned Revenue, Current - 125.3 157.3 598.7 900.3 -
Other Current Liabilities 2,564.0 613.9 1,358.4 2,686.9 2,356.0 10,070.3
Total Current Liabilities 10,763.3 12,498.3 9,633.6 15,672.3 19,553.8 25,384.1
Total Liabilities And Equity 64,794.4 73,598.0 81,192.9 86,127.9 91,830.7 111,984.7
Supplemental Items
Total Shares Out. on Filing Date 139.1 139.1 139.1 139.1 139.1 139.1
Total Shares Out. on Balance Sheet Date 139.1 139.1 139.1 139.1 139.1 139.1
Book Value/Share 227.95 239.43 237.9 233.71 239.6 219.8
Tangible Book Value 29,600.3 29,786.0 29,357.7 28,643.6 29,522.0 26,728.7
Tangible Book Value/Share 212.76 214.1 211.02 205.88 212.2 192.16
Total Debt 19,922.6 28,370.9 31,252.9 34,310.1 36,730.6 35,027.3
Net Debt 14,693.6 24,133.7 27,366.7 30,668.0 33,180.2 27,544.5
Debt Equiv. of Unfunded Proj. Benefit Obligation 141.4 161.4 187.3 215.1 413.2 NA
Debt Equivalent Oper. Leases 14,340.0 21,269.6 25,883.2 26,568.9 29,096.3 NA
Total Minority Interest 730.1 779.3 1,245.8 1,324.4 1,354.6 1,304.2
Equity Method Investments NA NA 2,785.1 2,763.5 3,654.5 3,276.0
Inventory Method FIFO FIFO FIFO FIFO FIFO NA
Raw Materials Inventory 218.2 335.7 370.3 223.5 150.4 NA
Finished Goods Inventory 3,059.8 3,559.5 4,107.3 5,196.6 5,433.5 NA
Other Inventory Accounts 224.6 166.2 191.1 238.3 263.9 NA
Land 2,856.1 3,346.9 3,303.5 3,609.0 4,706.2 NA
Buildings 8,468.4 12,846.6 16,567.7 17,401.5 14,741.0 NA
Machinery 21,626.0 21,043.0 25,947.4 29,404.6 32,704.5 NA
Construction in Progress 5,326.4 5,615.6 3,468.6 7,122.0 8,217.7 -
Leasehold Improvements 3,939.2 4,916.5 4,984.6 5,313.6 9,197.3 -
Full Time Employees 40,065 43,557 49,747 54,698 60,374 NA
Assets under Cap. Lease, Gross NA 67.2 NA NA NA NA
Assets under Cap. Lease, Accum. Depr. NA (11.1) NA NA NA NA
Accum. Allowance for Doubtful Accts NA 784.4 716.6 1,182.3 1,740.1 NA
Filing Date May-25-2016 Sep-22-2017 Sep-11-2018 Aug-30-2019 Aug-30-2019 Nov-14-2019
Restatement Type NC RS RS RS O P
Calculation Type REP REP REP REP REP REP
Note: For multiple class companies, total share counts are primary class equivalent, and for foreign companies listed as primary ADRs, total share counts are ADR-equivalent.
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) > Financials > Cash Flow
In Millions of INR, except per share items. Template: Standard Restatement: Latest Filings
Period Type: Annual Order: Latest on Right
Currency: Indian Rupee Conversion: Historical
Units: S&P Capital IQ (Defaul Decimals: Capital IQ (Default)
Cash Flow
LTM
Restated Restated Press Release
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019 Sep-30-2019
Currency INR INR INR INR INR INR
Supplemental Items
Cash Interest Paid 1,175.7 1,932.9 3,343.0 3,178.2 3,620.2 3,620.2
Cash Taxes Paid 1,002.8 1,411.9 1,336.2 1,251.0 1,924.3 1,924.3
Levered Free Cash Flow (5,991.3) (6,633.5) (5,037.8) 102.5 608.4 NA
Unlevered Free Cash Flow (5,345.3) (5,619.8) (3,610.1) 1,722.5 2,381.5 NA
Change in Net Working Capital 2,074.0 809.1 2,643.9 (1,576.2) (992.8) NA
Net Debt Issued 5,481.3 6,818.9 2,056.7 3,018.3 2,347.0 2,347.0
Filing Date May-25-2016 Sep-22-2017 Sep-11-2018 Aug-30-2019 Aug-30-2019 Nov-14-2019
Restatement Type NC RS RS NC O P
Calculation Type REP REP REP REP REP LTM
Average multiples are calculated using positive close values on each trading day within the frequency periods selected. Negative values are excluded from the calculation. When the Multiples are not meaningful, due to neg
When a mismatch exists between the currency of the equity listing and the reported financial results such results are translated into the currency of the listing at the exchange rate applicable on the financial period end date
Historical Capitalization
Balance Sheet as of:
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Pricing as of* Jul-28-2014 May-28-2015 May-25-2016 Sep-22-2017 Sep-11-2018 Aug-30-2019
Currency INR INR INR INR INR INR
Capitalization Detail
Share Price 1,022.1 1,222.25 1,339.9 1,034.7 1,108.4 1,508.15
Shares Out. 139.1 139.1 139.1 139.1 139.1 139.1
Book Value of Common Equity 29,766.8 31,713.3 34,536.5 36,713.6 32,515.1 33,334.7
+ Pref. Equity - - - - - -
+ Total Minority Interest 187.8 730.1 1,303.2 2,164.3 1,324.4 1,354.6
+ Total Debt 13,443.6 19,922.6 26,866.9 31,477.6 34,310.1 36,730.6
= Total Capital 43,398.2 52,366.0 62,706.6 70,355.4 68,149.5 71,419.9
* Pricing as of the filing date of the balance sheet period end date. For
TEV calculation purposes on this page Capital IQ only uses balance
sheet components from the original filing that is publicly available as of
a given pricing date and does not use restated balance sheet data
from a later filing. In the cases where a company did not disclose
balance sheet values for a particular period, TEV is calculated using
balance sheet components from the last reported balance sheet as of
this date. The table above is organized along period end dates.
** For companies that have multiple share classes that publicly trade,
we are incorporating the different prices to calculate our company level
market capitalization. Please click on the value to see the detailed
calculation. Prices shown on this page are the close price of the
company’s primary stock class. Shares shown on this page are total
company as-reported share values.
Available Credit
Undrawn Revolving Credit 9,048.9 - 8,635.4 - 5,058.5 -
Total Undrawn Credit 9,048.9 - 8,635.4 - 5,058.5 -
Additional Totals
Total Cash & ST Investments 3,886.3 - 3,642.1 - 3,550.4 -
Net Debt 27,366.7 - 30,668.0 - 33,180.2 -
Total Senior Debt 31,599.2 101.1% 34,362.7 100.2% 36,744.1 100.0%
Total Convertible Debt 8.8 0.0% 7.5 0.0% 7.5 0.0%
Total Short-Term Borrowings 706.9 2.3% 3,791.7 11.1% 4,981.6 13.6%
Curr. Port. of LT Debt/Cap. Leases 1,012.3 3.2% 1,236.7 3.6% 2,227.7 6.1%
Long-Term Debt (Incl. Cap. Leases) 29,533.8 94.5% 29,281.7 85.3% 29,521.3 80.4%
Total Bank Debt 23,276.2 74.5% 27,098.6 79.0% 29,548.3 80.4%
Total Secured Debt 29,625.4 94.8% 29,367.0 85.6% 31,256.4 85.1%
Senior Secured Loans 21,570.7 69.0% 22,326.4 65.1% 24,231.6 66.0%
Senior Secured Bonds and Notes 8,000.0 25.6% 7,000.0 20.4% 7,000.0 19.1%
Total Senior Secured Debt 29,625.4 94.8% 29,367.0 85.6% 31,256.4 85.1%
Total Unsecured Debt 1,973.9 6.3% 4,995.8 14.6% 5,487.7 14.9%
Senior Unsecured Bonds and Notes 8.8 0.0% 7.5 0.0% 7.5 0.0%
Fixed Rate Debt 28,479.2 91.1% 25,844.0 75.3% 26,380.4 71.8%
Variable Rate Debt 2,632.7 8.4% 4,779.1 13.9% 4,084.3 11.1%
Zero Coupon Debt 8.8 0.0% 7.5 0.0% 7.5 0.0%
Hedging Activities - - 43.7 0.1% - -
Credit Ratios
Net Debt/EBITDA 3.8x - 3.9x - 3.2x -
Total Debt/EBITDA 4.3x - 4.4x - 3.5x -
Total Senior Debt/EBITDA 4.4x - 4.4x - 3.5x -
Total Senior Secured/EBITDA 4.1x - 3.7x - 3.0x -
Net Debt/(EBITDA-CAPEX) 52.3x - 18.7x - 8.9x -
Total Debt/(EBITDA-CAPEX) 59.8x - 20.9x - 9.9x -
Total Senior Debt/(EBITDA-CAPEX) 60.4x - 20.9x - 9.9x -
Total Senior Secured/(EBITDA-CAPEX) 56.6x - 17.9x - 8.4x -
Coupon/Base
Description Type Principal Due (INR) Rate Floating Rate Maturity Seniority Secured
10.2% Non Convertible Bonds and Notes 2,000.0 10.200% NA Aug-22-2028 Senior Yes
Debentures
7.8% Non Convertible Bonds and Notes 2,000.0 7.800% NA Mar-07-2022 Senior Yes
Debentures
8.7% Non Convertible Bonds and Notes 3,000.0 8.700% NA Oct-07-2026 Senior Yes
Debentures
Axis Bank Cash Credit Facility Revolving Credit - 9.150% NA - Senior Yes
Borrowing - Dr GSK Velu Other Borrowings 24.2 14.000% NA - Senior No
Citi Bank - Bill Discounting Term Loans 588.2 8.000% NA - Senior No
Bank Loan
Cumulative Redeemable Other Borrowings 26.4 9.000% NA - Senior No
Preference Shares
ECB Loan - HSBC Bank Term Loans 277.3 9.500% NA Jul-01-2019 Senior Yes
ECB Loan - International Term Loans 891.8 9.200% NA - Senior Yes
Finance Corporation
Fixed Deposits Other Borrowings 13.4 8.750% - 9.250% NA Aug-01-2018 Senior No
HDFC - CC AC Facility Revolving Credit 570.8 0.000% NA Mar-31-2020 Senior Yes
HDFC Bills Payable Revolving Credit 150.2 NA NA - Senior No
HSBC - Cash Credit Facility Revolving Credit 148.0 8.750% NA - Senior No
HSBC Bills Payable Revolving Credit 131.7 NA 6-Month LIBOR + 0.550% - Senior Yes
Inter Corporate Deposit from Other Borrowings 97.2 12.000% NA - Senior No
Lavasa Corporation Limited
Loan - Axis Bank Term Loans 247.2 NA New Benchmark - Senior Yes
Loan - Axis Bank Limited Term Loans 2,925.0 8.600% NA Sep-15-2028 Senior Yes
Loan - Bank of India Term Loans 2,425.0 9.550% NA Sep-30-2028 Senior Yes
Loan - Bank of Tokyo - Term Loans 1,109.2 9.200% NA - Senior No
Mitsubishi UFJ
Loan - HDFC Bank Limited Term Loans 3,500.0 8.400% NA Mar-08-2031 Senior Yes
Loan - HDFC Bank Limited Term Loans 1,250.0 8.400% NA Mar-31-2020 Senior No
Loan - ICICI Bank Limited Term Loans 2,460.0 9.050% NA Mar-30-2031 Senior Yes
Loan - IDFC Bank Limited Term Loans 514.2 8.650% NA - Senior Yes
Loan - IDFC Infrastructure Term Loans 1,000.0 9.600% NA Dec-01-2031 Senior Yes
Finance Limited
Loan - Jugnu Jain - Director Other Borrowings 2.4 11.000% NA - Senior No
Loan - MUFG Bank Ltd. Term Loans 2,000.0 8.500% NA - Senior No
Loan - State Bank of India Term Loans 3,611.4 8.800% NA Feb-01-2029 Senior Yes
Optionally Convertible Bonds and Notes 7.5 NA NA - Senior No
Debentures
Overdraft Facility - Yes Bank Revolving Credit 71.1 9.400% NA - Senior No
Philips India Pvt Ltd - PET CT - Capital Lease 24.7 12.000% NA Dec-01-2020 Senior Yes
Finance Lease
Rupee Term Loan - HDFC Term Loans - 8.500% NA Jun-01-2018 Senior Yes
Bank Limited
Rupee Term Loan - HSBC Term Loans 1,825.0 8.300% NA 9-2-2024 - 2026 Senior Yes
Bank
Rupee Term Loans - HDFC Term Loans 144.0 10.200% NA Dec-02-2021 Senior Yes
Bank
Rupee Term Loans - Yes Bank Term Loans 148.4 9.800% NA Oct-01-2028 Senior Yes
Term Loan - Axis Bank Term Loans 820.2 8.850% NA - Senior Yes
Term Loan from HDFC Bank Term Loans 818.0 NA New Benchmark - Senior Yes
Term Loan from ICICI Bank Term Loans 354.4 NA New Benchmark - Senior Yes
Term Loan from Yes Bank Term Loans 1,283.0 NA New Benchmark - Senior Yes
Two Rupee Term Loans - Yes Term Loans 284.3 9.950% NA 12-26-2021 - 2026 Senior Yes
Bank
*Principal Due values translated into INR at an exchange rate of 1.000 INR/INR on Mar-31-2019.
Coupon/Base
Description Type Principal Due (INR) Rate Floating Rate Maturity Seniority Secured
10.2% Non Convertible Bonds and Notes 2,000.0 10.200% NA Aug-22-2028 Senior Yes
Debentures
7.8% Non Convertible Bonds and Notes 2,000.0 7.800% NA Mar-07-2022 Senior Yes
Debentures
8.7% Non Convertible Bonds and Notes 3,000.0 8.700% NA Oct-07-2026 Senior Yes
Debentures
Axis Bank Cash Credit Facility Revolving Credit 119.1 9.150% NA - Senior Yes
Borrowing - Dr GSK Velu Other Borrowings 0.3 14.000% NA - Senior No
Citi Bank - Bill Discounting Term Loans 754.1 8.000% NA - Senior No
Bank Loan
Cumulative Redeemable Other Borrowings 19.9 9.000% NA - Senior No
Preference Shares
ECB Loan - HSBC Bank Term Loans 650.3 9.500% NA Jul-01-2019 Senior Yes
ECB Loan - International Term Loans 1,115.4 9.200% NA - Senior Yes
Finance Corporation
Fixed Deposits Other Borrowings 96.3 8.750% - 9.250% NA Aug-01-2018 Senior No
HDFC Bills Payable Revolving Credit - NA NA - Senior No
HSBC - Cash Credit Facility Revolving Credit 817.7 8.750% NA - Senior No
HSBC Bills Payable Revolving Credit 329.4 NA 6-Month LIBOR + 0.550% - Senior Yes
Inter Corporate Deposit from Other Borrowings 97.2 12.000% NA - Senior No
Lavasa Corporation Limited
Loan - Axis Bank Term Loans 248.0 NA New Benchmark - Senior Yes
Loan - Axis Bank Limited Term Loans 3,000.0 8.600% NA Sep-15-2028 Senior Yes
Loan - Bank of India Term Loans 2,500.0 9.550% NA Sep-30-2028 Senior Yes
Loan - Bank of Tokyo - Term Loans 1,300.3 9.200% NA - Senior No
Mitsubishi UFJ
Loan - HDFC Bank Limited Term Loans 3,500.0 8.400% NA Mar-08-2031 Senior Yes
Loan - HDFC Bank Limited Term Loans 1,830.0 8.400% NA Mar-31-2020 Senior No
Loan - ICICI Bank Limited Term Loans 1,450.0 9.050% NA Mar-30-2031 Senior Yes
Loan - IDFC Bank Limited Term Loans 548.5 8.650% NA - Senior Yes
Loan - IDFC Infrastructure Term Loans 1,000.0 9.600% NA Dec-01-2031 Senior Yes
Finance Limited
Loan - Jugnu Jain - Director Other Borrowings 2.4 11.000% NA - Senior No
Loan - State Bank of India Term Loans 2,050.4 8.800% NA Feb-01-2029 Senior Yes
Optionally Convertible Bonds and Notes 7.5 NA NA - Senior No
Debentures
Overdraft Facility - Yes Bank Revolving Credit 70.1 9.400% NA - Senior No
Philips India Pvt Ltd - PET CT - Capital Lease 40.6 12.000% NA Dec-01-2020 Senior Yes
Finance Lease
Rupee Term Loan - HDFC Term Loans 48.0 8.500% NA Jun-01-2018 Senior Yes
Bank Limited
Rupee Term Loan - HSBC Term Loans 1,925.0 8.300% NA 9-2-2024 - 2026 Senior Yes
Bank
Rupee Term Loans - HDFC Term Loans 216.0 10.200% NA Dec-02-2021 Senior Yes
Bank
Term Loan - Axis Bank Term Loans 919.9 8.850% NA - Senior Yes
Term Loan from HDFC Bank Term Loans 310.0 NA New Benchmark - Senior Yes
Term Loan from ICICI Bank Term Loans 210.4 NA New Benchmark - Senior Yes
Term Loan from Yes Bank Term Loans 1,851.3 NA New Benchmark - Senior Yes
Two Rupee Term Loans - Yes Term Loans 334.7 9.950% NA 12-26-2021 - 2026 Senior Yes
Bank
Repayme
nt
Convertible Currency
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
Convertible INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
Repayme
nt
Convertible Currency
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No
No INR
No INR
No INR
No INR
No INR
No INR
No INR
Convertible INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
No INR
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) > Financials > Ratios
Restatement: Latest Filings Period Type: Annual
Order: Latest on Right Decimals: Capital IQ (Default)
Ratios
LTM
Press Release
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019 Sep-30-2019
Profitability
Return on Assets % 5.6% 3.9% 3.4% 3.3% 4.7% NA
Return on Capital % 6.9% 4.7% 4.1% 4.1% 6.0% NA
Return on Equity % 10.7% 7.1% 3.8% 1.7% 5.8% NA
Return on Common Equity % 11.1% 7.3% 6.7% 3.6% 7.2% NA
Margin Analysis
Gross Margin % 33.5% 34.4% 32.7% 32.9% 33.9% 34.0%
SG&A Margin % 6.5% 6.8% 6.3% 6.1% 5.7% 5.3%
EBITDA Margin % 14.3% 11.1% 10.0% 9.5% 10.9% 11.8%
EBITA Margin % 10.3% 7.0% 5.9% 5.4% 7.0% 8.1%
EBIT Margin % 10.2% 6.9% 5.8% 5.4% 7.0% 8.1%
Earnings from Cont. Ops Margin % 6.5% 3.8% 1.8% 0.7% 2.1% 2.4%
Net Income Margin % 6.6% 3.8% 3.0% 1.4% 2.5% 2.7%
Net Income Avail. for Common Margin % 6.6% 3.8% 3.0% 1.4% 2.5% 2.7%
Normalized Net Income Margin % 5.5% 3.1% 3.2% 2.1% 2.8% 2.9%
Levered Free Cash Flow Margin % (11.6%) (10.7%) (6.9%) 0.1% 0.6% NA
Unlevered Free Cash Flow Margin % (10.3%) (9.0%) (5.0%) 2.1% 2.5% NA
Asset Turnover
Total Asset Turnover 0.9x 0.9x 0.9x 1.0x 1.1x NA
Fixed Asset Turnover 1.6x 1.6x 1.7x 1.7x 1.8x NA
Accounts Receivable Turnover 9.2x 10.2x 10.6x 10.0x 9.7x NA
Inventory Turnover 10.9x 10.8x 11.2x 10.7x 11.1x NA
Supplemental
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Currency INR INR INR INR INR INR
Stock Based Compensation
Stock Based Comp. Exp., Before Tax - - - 4.4 6.2 9.1
Industry Specific
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Currency INR INR INR INR INR INR
Facility Stats
Consolidated Hospitals and Facilities - - - - - 830
Non-Consolidated Hospitals and Facilities - - - - - 5
Total Hospitals and Facilities - - - - - 835
Licensed Beds 6,684 7,207 8,120 8,850 8,910 9,233
Beds in Service 5,811 6,321 6,724 6,940 7,111 7,246
Admissions 331,678 - - - - 450,000
Patient Days 1,505,990 1,567,310 1,559,892 1,620,965 1,704,550 1,802,370
Inpatient Surgeries and Procedures - - - - - 48,830
Total Surgeries and Procedures - - - - - 48,830
ER Visits 2,943,610 3,203,279 3,323,159 3,574,840 3,772,878 4,161,736
Average Daily Census 4,126.0 4,294.0 4,262.0 4,441.0 4,670.0 4,938.0
Average Length of Stay (Days) 4.5 4.4 4.2 4.0 4.0 4.0
Occupancy Rate 71.0% 68.0% 63.0% 64.0% 66.0% 68.0%
Expenses as % of Revenue
Salaries and Benefits 16.5% 16.5% 16.4% 16.4% 17.0% 16.6%
Supplies 23.6% 22.4% 20.2% 18.8% 17.7% 17.1%
Provisions for Doubtful Accounts 0.5% 0.5% 0.6% 0.4% 0.7% 0.7%
Other Operating Expenses 5.5% 20.5% 35.7% 26.2% 28.2% 28.0%
Other Items
Net Patient Revenues 27,341.7 31,067.5 27,864.8 44,464.6 49,544.4 57,078.9
Pension/OPEB
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Currency INR INR INR INR INR INR
Pension Information - Total
Defined Benefit Net Periodic Cost
Def. Benefit Service Cost 46.4 52.8 100.7 63.2 75.5 97.4
Def. Benefit Plan Interest Cost 31.0 36.7 - 44.9 51.3 -
Def. Benefit Plan Return on Assets (25.7) (30.5) - (42.8) (43.9) -
Def. Benefit Net Interest Cost & Income - - 1.1 - - 67.6
Def. Benefit Plan Other Cost 132.8 108.0 (2.7) 2.0 12.2 7.4
Def. Benefit Plan Total Cost 184.5 167.1 99.0 67.3 95.1 172.5
Plan Assets
Beg. Plan Assets 326.2 315.2 482.8 491.1 601.0 743.9
Actual Return on Plan Assets (38.3) 3.2 163.8 60.4 28.3 68.1
Employer Contributions 94.3 210.2 106.1 95.8 164.0 185.6
Benefits Paid (67.1) (81.5) 24.0 (46.3) (49.4) (87.5)
Other Plan Adjustments - - (76.1) - - -
Total Plan Assets 315.2 447.1 700.6 601.0 743.9 910.1
Plan Assets
Beg. Plan Assets 326.2 315.2 482.8 491.1 601.0 743.9
Actual Return on Plan Assets (38.3) 3.2 163.8 60.4 28.3 68.1
Employer Contributions 94.3 210.2 106.1 95.8 164.0 185.6
Benefits Paid (67.1) (81.5) 24.0 (46.3) (49.4) (87.5)
Other Plan Adjustments - - (76.1) - - -
Total Plan Assets 315.2 447.1 700.6 601.0 743.9 910.1
Business Segments
Restated Reclassified Restated Restated Reclassified
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Currency INR INR INR INR INR INR
Revenues
Healthcare 29,594.3 33,330.7 36,998.1 40,819.2 45,246.5 51,618.5
Retail Pharmacy 13,648.4 17,725.5 23,219.7 27,851.9 32,688.8 38,860.4
Clinics - - 521.6 3,854.1 4,589.2 5,887.5
Others 846.4 1,132.2 1,893.7 298.2 69.9 39.7
Inter Segment Revenue - - (36.3) (41.5) (159.8) (231.6)
Corporate (32.3) (36.3) - - - -
Total Revenues 44,056.9 52,152.1 62,596.8 72,782.0 82,434.7 96,174.4
Assets
Healthcare 41,963.3 50,513.2 55,313.0 61,433.1 65,393.9 67,823.7
Retail Pharmacy 3,842.0 5,967.0 6,936.2 7,691.2 9,372.4 11,233.5
Clinics - - 4,795.8 5,681.7 5,058.1 4,580.5
Others 3,715.9 3,609.5 3,580.0 4,886.2 645.4 505.3
Unallocated - - - 1,500.7 5,658.1 7,687.7
Unallocated Corporate Assets - - 897.1 - - -
Unallocated Goodwill - - 2,075.9 - - -
Corporate 4,203.5 4,704.8 - - - -
Total Assets 53,724.8 64,794.4 73,598.0 81,192.9 86,127.9 91,830.7
Capital Expenditure
Healthcare (5,200.8) (7,996.0) (8,522.8) - - -
Retail Pharmacy (234.0) (310.0) (1,501.6) - - -
Clinics - - (1,215.1) - - -
Others (15.9) (10.3) (12.1) - - -
Total Capital Expenditure (5,450.7) (8,316.2) (11,251.5) - - -
Geographic Segments
Restated Reclassified Restated Restated Reclassified
For the Fiscal Period Ending 12 months 12 months 12 months 12 months 12 months 12 months
Mar-31-2014 Mar-31-2015 Mar-31-2016 Mar-31-2017 Mar-31-2018 Mar-31-2019
Currency INR INR INR INR INR INR
Revenues
India 43,842.2 51,784.5 62,146.5 72,557.0 82,434.7 96,174.4
Total Revenues 43,842.2 51,784.5 62,146.5 72,557.0 82,434.7 96,174.4
Interest Expense
India (1,074.4) (1,033.6) (1,621.9) (2,284.3) (2,592.1) (2,837.0)
Total Interest Expense (1,074.4) (1,033.6) (1,621.9) (2,284.3) (2,592.1) (2,837.0)
Tax Expense
India 1,017.6 1,300.0 969.0 909.6 1,119.1 1,733.7
Total Tax Expense 1,017.6 1,300.0 969.0 909.6 1,119.1 1,733.7
Assets
India 53,724.8 64,794.4 73,598.0 81,192.9 86,127.9 91,830.7
Total Assets 53,724.8 64,794.4 73,598.0 81,192.9 86,127.9 91,830.7
Capital Expenditure
India (6,118.9) (8,680.6) (10,159.0) (6,734.5) (6,213.9) (6,789.2)
Total Capital Expenditure (6,118.9) (8,680.6) (10,159.0) (6,734.5) (6,213.9) (6,789.2)